We found that although induced in COVID‐19, IL1B expression was not different between ND and T2D patients (Appendix Fig S2F), whereas other inflammatory markers related to the type 1 interferon signature were increased in COVID‐19 and further increased with comorbid T2D (Appendix Fig S2F). This evidence concerns the gene IL1B and COVID-19.